Updates from The Motley Fool

Latest updates on ChemoCentryx, Inc. from Fool.com.


Stock Performance

CCXI vs. S&P 500 | 2 Year Performance
CCXI 1-Day Stock Chart
CCXI 5-Day Stock Chart
CCXI 1-Month Stock Chart
CCXI 3-Month Stock Chart
CCXI 6-Month Stock Chart
CCXI 1-Year Stock Chart
CCXI 2-Year Stock Chart
CCXI 5-Year Stock Chart
View Interactive CCXI Charts
Sponsored by

Key Data Points

Primary metrics and data points about ChemoCentryx, Inc. .
Current Price: $2.23
Prev Close: $2.38
Open: $2.37
Bid: $2.15
Ask: $3.60
Day's Range: $2.23 - $2.45
52wk Range: $2.16 - $9.46
Volume: 126,357
Avg Vol 236,055
Market Cap: $98.41M
P/E (ttm): 2.20
EPS (ttm): $1.08
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ChemoCentryx, Inc. .
CAPS Rating 3 out of 5
 
53 Outperform
4 Underperform
CAPS All Stars
 
15 Outperform
3 Underperform

How do you think ChemoCentryx, Inc. will perform against the market?



You pick for ChemoCentryx, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Thomas J. Schall, CEO

0% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ChemoCentryx, Inc. .

Chemocentryx Inc. is a biopharmaceutical company focused on discovering developing and commercializing orally-administered therapeutics to treat autoimmune diseases inflammatory disorders and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers